Floatz logo

Therapeutic Asset Ratings

193 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
ilb2109
endometrial carcinoma
Innolake BiopharmP1/2CC (41)
Immunoglobulin G1 [240-alanine,241-alanine], anti-(human folate receptor ?) (human monoclonal PRO1184 ?1-chain, complex with human monoclonal PRO1184 ?-chain, dimer, 214??,214???,226,226?,232,232?,235,235?-octakis(thioether) with N6-[39-[bis(1-deoxy-D-glucitol-1-yl)amino]-1-oxo-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxanonatriacont-1-yl]-N2-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-lysyl-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]methyl]phenyl]-L-ornithinamide
endometrial carcinoma
GenmabP1/2CC (41)
Immunoglobulin G4 [237-proline,242-proline,243-valine,244-alanine,de-245-glycine], anti-(human mucin-16) (human monoclonal REGN5668 ?4-chain), disulfide with human monoclonal REGN5668 ?-chain, (235?228?),(238?231?)-bis(disulfide) with immunoglobulin G4 [230-proline,235-proline,236-valine,237-alanine,de-238-glycine,436-arginine,437-phenylalanine,446-proline] anti-(human CD28 antigen) (human monoclonal REGN5668 ?4-chain) disulfide with human monoclonal REGN5668 ?-chain
endometrial carcinoma
Regeneron PharmaceuticalsP1/2CC (41)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
endometrial carcinoma
Regeneron PharmaceuticalsP1/2CC (41)
Inv-6452
endometrial carcinoma
Shenzhen Ionova Life Sciences Co., Ltd.P1/2CC (41)
Inv-8989
endometrial carcinoma
Shenzhen Ionova Life Sciences Co., Ltd.P1/2CC (41)
Iparomlimab
Endometrial Cancer
Qilu Pharmaceutical Co., Ltd.P1/2CC (41)
mdx2001
endometrial carcinoma
ModeX Therapeutics, An OPKO Health CompanyP1/2CC (41)
mt-4561
endometrial carcinoma
Tanabe Pharma America, Inc.P1/2CC (41)
Neoantigen Specific Tcr-T Cell Drug Product
endometrial carcinoma
Alaunos TherapeuticsP1/2CC (41)
Palacaparib
endometrial carcinoma
AstraZenecaP1/2CC (41)
Pasifolate Exatecan
endometrial carcinoma
Elucida OncologyP1/2CC (41)
ql2107
endometrial carcinoma
Qilu Pharmaceutical Co., Ltd.P1/2CC (41)
qls5132
endometrial carcinoma
Qilu Pharmaceutical Co., Ltd.P1/2CC (41)
Rezatapopt
endometrial carcinoma
PMV Pharmaceuticals, IncP1/2CC (41)
Sarilumab
endometrial carcinoma
Regeneron PharmaceuticalsP1/2CC (41)
SL-28
endometrial carcinoma
Second Life TherapeuticsP1/2CC (41)
t3011
endometrial carcinoma
ImmVira Pharma Co. LtdP1/2CC (41)
tcc1727
endometrial carcinoma
Beijing Tide Pharmaceutical Co., LtdP1/2CC (41)
T-Dxd
endometrial carcinoma
AstraZenecaP1/2CC (41)
Ter-2013
endometrial carcinoma
Terremoto Biosciences Inc.P1/2CC (41)
TESTOSTERONE UNDECYLATE
Endometrial Cancer
Aminex Therapeutics, Inc.P1/2CC (41)
Tocilizumab
endometrial carcinoma
Regeneron PharmaceuticalsP1/2CC (41)
Toripalimab
endometrial carcinoma
Innolake BiopharmP1/2CC (41)
Torvutatug Samrotecan
endometrial carcinoma
AstraZenecaP1/2CC (41)
Showing 101 to 125 of 193 assets
PreviousPage 5 of 8Next